Quoting Amar Gajjar on Twitter:
”SJ901, named after the last 3 digits of the experimental SpringWorks drug, offers a new targeted therapeutic approach against pediatric low-grade gliomas. Giles Robinson.”
For the article click here.
Source: Amar Gajjar/Twitter